Clinical Trials Directory

Trials / Completed

CompletedNCT04105998

Effects of Intramuscular (IM) Oxytocin on Pupil Diameter and Heart Rate Variability (HRV)

Effects of Intramuscular Oxytocin on Pupil Diameter and Heart Rate Variability

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years – 66 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to test the effects of oxytocin on heart rate variability and pupil diameter, both of which have subtle effects on the activity rate of the autonomic nervous system.

Detailed description

This protocol focuses on two measures of autonomic control to quantify central actions of oxytocin. First, the study team proposes to examine the influence of oxytocin on heart rate variability with focus on its effect on high frequency variability, most commonly ascribed to parasympathetic nervous system activity acting to brake sympathetic tone. Intranasal oxytocin has been demonstrated to have a large effect size on this measure which can be repeated at frequent intervals. As a secondary assessment of parasympathetic activity, the study team will measure low frequency fluctuation in pupil diameter, termed hippus, which also reflects parasympathetic nervous system activity. This outcome measure can be assessed in 3 seconds using equipment currently being used under Institutional Review Board (IRB) approved protocols.

Conditions

Interventions

TypeNameDescription
DRUGOxytocinOxytocin 10 IU
DRUGPlaceboPlacebo

Timeline

Start date
2019-10-24
Primary completion
2021-11-01
Completion
2021-11-01
First posted
2019-09-26
Last updated
2022-11-10
Results posted
2022-11-10

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04105998. Inclusion in this directory is not an endorsement.